Chris H. Bangma

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · The Lancet · 2014 · 1.6K citations · Full text

Medicine, Oncology, Urology +13

Prostate-Cancer Mortality at 11 Years of Follow-up

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

Medicine, Oncology, Urology +8

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology · 2012 · 542 citations

Medicine, Oncology, Urology +16

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

William J. Catàlona, Alan W. Partin, Martin G. Sanda et al. · The Journal of Urology · 2011 · 493 citations · Full text

Medicine, Oncology, Urology +15

Quality-of-Life Effects of Prostate-Specific Antigen Screening

Eveline A.M. Heijnsdijk, Elisabeth M. Wever, Anssi Auvinen et al. · New England Journal of Medicine · 2012 · 425 citations · Full text

Medicine, Oncology, Urology +7